相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Ivonne Regel et al.
CANCERS (2020)
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
Caitlin A. McIntyre et al.
CANCER (2020)
Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids
Anna E. Vilgelm et al.
ISCIENCE (2020)
Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine
William H. Gmeiner
MOLECULES (2020)
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Lei Huang et al.
GUT (2019)
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
Sorah Yoon et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E. Hessmann et al.
GUT (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy
Christopher C. Mills et al.
CANCER RESEARCH (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Therapeutic aptamers in discovery, preclinical and clinical stages
Said I. Ismail et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
2-Fluoro-Pyrimidine-Modified RNA Aptamers Specific for Lipopolysaccharide Binding Protein (LBP)
Jasmin Aldag et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials
Alessandro Ottaiano et al.
ACTA ONCOLOGICA (2017)
Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells
Simone Benitz et al.
ONCOTARGET (2016)
Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer
Ujjwal M. Mahajan et al.
GUT (2016)
Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma
James D. Byrne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Analysis of lipid-composition changes in plasma membrane microdomains
Hideo Ogiso et al.
JOURNAL OF LIPID RESEARCH (2015)
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Anders Wittrup et al.
NATURE BIOTECHNOLOGY (2015)
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Madduri Srinivasarao et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A Theranostic SMART Aptamer for Targeted Therapy of Prostate Cancer
Vittorio de Franciscis
MOLECULAR THERAPY (2014)
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
Vanessa Almendro et al.
CELL REPORTS (2014)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma
Matias E. Valsecchi et al.
CANCER (2012)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
Targeted Drug Delivery and Penetration Into Solid Tumors
Angelo Corti et al.
MEDICINAL RESEARCH REVIEWS (2012)
Aptamer-Mediated Delivery of Chemotherapy to Pancreatic Cancer Cells
Partha Ray et al.
NUCLEIC ACID THERAPEUTICS (2012)
Drug Efflux Transporter Multidrug Resistance-Associated Protein 5 Affects Sensitivity of Pancreatic Cancer Cell Lines to the Nucleoside Anticancer Drug 5-Fluorouracil
Praveen K. Nambaru et al.
DRUG METABOLISM AND DISPOSITION (2011)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Standard steroid treatment for autoimmune pancreatitis
T. Kamisawa et al.
GUT (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Endocytic mechanisms for targeted drug delivery
Lisa A. Bareford et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The use of targeted mouse models for preclinical testing of novel cancer therapeutics
Kenneth P. Olive et al.
CLINICAL CANCER RESEARCH (2006)
Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
Paula M. De Angelis et al.
MOLECULAR CANCER (2006)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Detection and quantitation of RNA base modifications
XL Zhao et al.
RNA (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Advancing the field of drug delivery: Taking aim at cancer
MA Moses et al.
CANCER CELL (2003)
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients
A Di Paolo et al.
ANNALS OF ONCOLOGY (2001)
分享论文
